Why it was recalled
Subpotent Drug
Product description
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
Lot numbers, UPCs & expiration codes
Lot 16240062A, exp date 3/2026
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0403-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Feb 26, 2026
- FDA report date
- Apr 1, 2026
- Quantity
- 1315 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- MACLEODS PHARMA USA, INC
Original FDA data
Every field from FDA enforcement report D-0403-2026, exactly as published.
Show all FDA fields
- City
- Princeton
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98510
- Address
- 103 College Rd E Fl 2
- Code information
- Lot 16240062A, exp date 3/2026
- Postal code
- 08540-6611
- Report date
- Apr 1, 2026
- Product type
- Drugs
- Recall number
- D-0403-2026
- Classification
- Class II
- Recalling firm
- MACLEODS PHARMA USA, INC
- Product quantity
- 1315 bottles
- Reason for recall
- Subpotent Drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
- Distribution pattern
- Nationwide
- Recall initiation date
- Feb 26, 2026
- Initial firm notification
- Letter
- Center classification date
- Mar 24, 2026